The Indian pharmaceutical contract manufacturing market is anticipated to grow at a favourable CAGR of around 13.3% during the forecast period (2024-2031). The prominent factor that boosts the growth of the Indian pharmaceutical contract manufacturing market, are the growing aging population, emerging medical conditions, and the emergence of new diseases. The Indian pharma industry has achieved significant growth in both domestic and global markets during the forecast period. The pharma industry in India contributes more than 20% by volume of the global generics market and 62% of the global demand for vaccines. The Indian domestic pharmaceutical market size has reached $20.3 billion in 2019 with a growth of 9.8%, according to the University of New Mexico.
Get Free Sample link @ https://www.omrglobal.com/request-sample/indian-pharmaceutical-contract-manufacturing-market
The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2020, Roche Pharma expanded its partnership with Cipla to further improve access to the key oncology medicines in India. With this partnership, Roche Pharma expands the scope of marketing and distribution of oncology drugs trastuzumab, bevacizumab, and rituximab in India.
Full report of Indian Pharmaceutical Contract Manufacturing Market available @ https://www.omrglobal.com/industry-reports/indian-pharmaceutical-contract-manufacturing-market
Market Coverage
- Segment Covered- by category, by type, by product, by services
- Competitive Landscape- Dishman Group, Dr Reddy’s Laboratories Ltd., Gracure Pharmaceuticals Ltd., Jubilant Pharmova Ltd., Piramal Group, Divis Laboratories Ltd., Dupen Laboratories, Finecure Pharmaceuticals Ltd., Green Cross Remedies, and others.
- Key questions addressed by the report
- What is the market growth rate?
- Which segment dominates the market in the base year?
- Which segment will project the fastest growth in the market?
- How has COVID-19 impacted the market?
o Recovery Timeline
o Deviation from the pre-COVID forecast
o Most affected segment
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
Indian Pharmaceutical Contract Manufacturing Market– Segmentation
By Category
- Human Based Drugs
- Animals Based Drugs
By Type
- Sterile Manufacturing
- Non-Sterile Manufacturing
By Product
- Over-the-Counter (Otc) Drugs
- Active Pharmaceutical Ingredients (Api)
- Finished Dosage Formulation (Solid Dose, Liquid Dose and Injectable Dose)
- Others (Nutritional Products And Packaging)
By Services
- Manufacturing Services
- Non-Clinical Services such as Supply Chain Management
- Research and Development
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/indian-pharmaceutical-contract-manufacturing-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.